1-9 of 9
Thomas J. Raife
Close
Sort by
Journal Articles

Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site

Thomas J. Raife, Wenjing Cao, Bonnie S. Atkinson, Bruce Bedell, Robert R. Montgomery, Steven R. Lentz, George F. Johnson, X. Long Zheng
Journal: Blood
Blood (2009) 114 (8): 1666–1674.
https://doi.org/10.1182/blood-2009-01-195461
Published: 2009
Journal Articles

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Anaadriana Zakarija, MD, Hau C. Kwaan, MD PhD, Nicholas Banderanko, MD, Dilip K. Pandey, MD PhD, John F. Cursio, MS, Ivy M. Weiss, BA, Thanh Ha Luu, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD PhD, Thomas J. Raife, MD, Ravindra Sarode, MD, Charles L. Bennett, MD PhD MPP
Journal: Blood
Blood (2007) 110 (11): 1320.
https://doi.org/10.1182/blood.V110.11.1320.1320
Published: 2007
Journal Articles

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Charles L. Bennett, MD, PhD, MPP, Thanh Ha Luu, BA, Anaadriana Zakarija, MD, Hau C. Kwaan, MD, PhD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, John F. Cursio, MS, June M. McKoy, MD, JD, MPH, Charlie Buffie, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD, Ravindra Sarode, MD, X. Long Zheng, MD, PhD, Thomas J. Raife, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Gail A. Rock, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2088.
https://doi.org/10.1182/blood.V110.11.2088.2088
Published: 2007
Journal Articles

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Elizabeth A. Richey, BA, Charles L. Bennett, MD, PhD, MPP, Hau C. Kwaan, MD, PhD, Anaadriana Zakarija, MD, MSCI, Nicholas Banderanko, MD, Dilip K. Pandey, MD, PhD, June M. McKoy, MD, JD, MPH, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Jeffrey L. Winters, MD, Thomas J. Raife, MD, John F. Cursio, MS, Matthew J. Fisher, Thomas L. Ortel, MD, PhD, Martin S. Tallman, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Joel L. Moake, MD
Journal: Blood
Blood (2007) 110 (11): 2089.
https://doi.org/10.1182/blood.V110.11.2089.2089
Published: 2007
Journal Articles

Prognostic Indicators in Severely ADAMTS13 Deficient TMA Patients.

Yasuko O. Erickson, MD, Noelle I. Samia, PhD, Bruce Bedell, BS, Thomas J. Raife, MD
Journal: Blood
Blood (2006) 108 (11): 3989.
https://doi.org/10.1182/blood.V108.11.3989.3989
Published: 2006
Journal Articles

Targeted Replacement of the Murine Thrombomodulin Gene with Human Thrombomodulin Coding Sequence Results in Decreased Protein C Activation and Enhanced Thrombotic Response to Photochemical Injury.

Thomas J. Raife, MD, Rochelle A. Erger, Katina M. Wilson, Jose A. Fernandez, MD, PhD, Jennifer Alternburg, Hyung-Suk Kim, John H. Griffin, PhD, Nobuyo Maeda, PhD, Steven R. Lentz, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2980.
https://doi.org/10.1182/blood.V104.11.2980.2980
Published: 2004
Journal Articles

Eve of an ADAMTS13 breakthrough

Thomas J. Raife
Journal: Blood
Blood (2003) 102 (9): 3079–3080.
https://doi.org/10.1182/blood-2003-08-2842
Published: 2003
Journal Articles

Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor–cleaving protease activity

Clinical Trials & Observations
Thomas J. Raife, Steven R. Lentz, Bonnie S. Atkinson, Sara K. Vesely, Martin J. Hessner
Journal: Blood
Blood (2002) 99 (2): 437–442.
https://doi.org/10.1182/blood.V99.2.437
Published: 2002
Journal Articles

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Thomas J. Raife, John D. Olson, Steven R. Lentz
Journal: Blood
Blood (1997) 89 (3): 1112–1114.
https://doi.org/10.1182/blood.V89.3.1112
Published: 1997